{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:47:15Z","timestamp":1792788435892,"version":"4.5.0"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To determine whether disease remission or low disease activity state at the beginning of pregnancy in SLE patients is associated with better pregnancy outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Pregnancies in SLE patients prospectively monitored by pregnancy clinics at four rheumatology centres were enrolled. Patient demographics and clinical information were collected at baseline (pregnancy visit before 8\u2009weeks of gestation) including whether patients were in remission according to the Definition of Remission in SLE (DORIS) criteria and and\/or Lupus Low Disease Activity State (LLDAS). Univariate and multivariate analysis were performed to determine predictors of disease flare and adverse pregnancy outcomes (APOs) including preeclampsia, preterm delivery, small for gestational age infant, intrauterine growth restriction and intrauterine fetal death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 347 pregnancies were observed in 281 SLE patients. Excluding early pregnancy losses, 212 pregnancies (69.7%) occurred in patients who were in remission at baseline, 33 (10.9%) in patients in LLDAS, and the remainder in active patients. Seventy-three flares (24%) were observed during pregnancy or puerperium, and 105 (34.5%) APOs occurred. Multivariate analysis revealed that patients in disease remission or taking HCQ were less likely to have disease flare, while a history of LN increased the risk. The risk of APOs was increased in patients with shorter disease duration, while being on HCQ resulted a protective variable. An almost significant association between complete remission and a decreased risk of APOs was observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Prenatal planning with a firm treat-to-target goal of disease remission is an important strategy to reduce the risk of disease flares and severe obstetric complications in SLE pregnancies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab155","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T15:35:44Z","timestamp":1613144144000},"page":"5610-5619","source":"Crossref","is-referenced-by-count":51,"title":["Are remission and low disease activity state ideal targets for pregnancy planning in systemic lupus erythematosus? A multicentre study"],"prefix":"10.1093","volume":"60","author":[{"given":"Chiara","family":"Tani","sequence":"first","affiliation":[{"name":"Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2161-2562","authenticated-orcid":false,"given":"Dina","family":"Zucchi","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabell","family":"Haase","sequence":"additional","affiliation":[{"name":"Policlinic and Hiller Research Unit for Rheumatology, Heinrich Heine University Duesseldorf, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Larosa","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Medicine (DIMED), University of Padova, Padova"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Crisafulli","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, Rheumatology and Clinical Immunology Unit, ASST Spedali Civili, Brescia, University of Brescia, Brescia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca A L","family":"Strigini","sequence":"additional","affiliation":[{"name":"Division of Gynecology and Obstetrics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Monacci","sequence":"additional","affiliation":[{"name":"Division of Gynecology and Obstetrics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Elefante","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8915-7837","authenticated-orcid":false,"given":"Johanna","family":"Mucke","sequence":"additional","affiliation":[{"name":"Policlinic and Hiller Research Unit for Rheumatology, Heinrich Heine University Duesseldorf, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3760-2737","authenticated-orcid":false,"given":"May Y","family":"Choi","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Andreoli","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, Rheumatology and Clinical Immunology Unit, ASST Spedali Civili, Brescia, University of Brescia, Brescia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Iaccarino","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Medicine (DIMED), University of Padova, Padova"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Tincani","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, Rheumatology and Clinical Immunology Unit, ASST Spedali Civili, Brescia, University of Brescia, Brescia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0548-4983","authenticated-orcid":false,"given":"Andrea","family":"Doria","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Medicine (DIMED), University of Padova, Padova"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Fischer-Betz","sequence":"additional","affiliation":[{"name":"Policlinic and Hiller Research Unit for Rheumatology, Heinrich Heine University Duesseldorf, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mosca","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,2,16]]},"reference":[{"key":"2021121823172969600_keab155-B1","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/annrheumdis-2016-209519","article-title":"A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)","volume":"76","author":"van Vollenhoven","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021121823172969600_keab155-B2","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1136\/annrheumdis-2015-207726","article-title":"Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)","volume":"75","author":"Franklyn","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2021121823172969600_keab155-B3","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1002\/art.34672","article-title":"Predictors of organ damage in systemic lupus erythematosus: the Hopkins Lupus Cohort","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2021121823172969600_keab155-B4","doi-asserted-by":"crossref","first-page":"e000234","DOI":"10.1136\/lupus-2017-000234","article-title":"Remission and low disease activity in systemic lupus erythematosus: an achievable goal even with fewer steroids? Real-life data from a monocentric cohort","volume":"5","author":"Tani","year":"2018","journal-title":"Lupus Sci Med"},{"key":"2021121823172969600_keab155-B5","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1002\/art.40571","article-title":"Comparison of remission and lupus low disease activity state in damage prevention in a United States systemic lupus erythematosus cohort","volume":"70","author":"Petri","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2021121823172969600_keab155-B6","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.3899\/jrheum.131137","article-title":"Prolonged clinical remission in patients with systemic lupus erythematosus","volume":"41","author":"Steiman","year":"2014","journal-title":"J Rheumatol"},{"key":"2021121823172969600_keab155-B7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/rheumatology\/kew377","article-title":"Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus","volume":"56","author":"Tsang","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2021121823172969600_keab155-B8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/annrheumdis-2017-211613","article-title":"Lupus low disease activity state is associated with a decrease in damage progression in Caucasian patients with SLE, but overlaps with remission","volume":"77","author":"Zen","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2021121823172969600_keab155-B9","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/acr.23720","article-title":"Clinical remission and low disease activity outcomes over 10 years in systemic lupus erythematosus","volume":"71","author":"Tselios","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2021121823172969600_keab155-B10","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1136\/annrheumdis-2016-210382","article-title":"Prevalence of remission and its effect on damage and quality of life in Chinese patients with systemic lupus erythematosus","volume":"76","author":"Mok","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021121823172969600_keab155-B11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13075-017-1256-6","article-title":"Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study","volume":"19","author":"Golder","year":"2017","journal-title":"Arthritis Research Ther"},{"key":"2021121823172969600_keab155-B12","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1177\/0961203319876998","article-title":"Remission and low disease activity state prevent hospitalizations in systemic lupus erythematosus patients","volume":"28","author":"Re\u00e1tegui-Sokolova","year":"2019","journal-title":"Lupus"},{"key":"2021121823172969600_keab155-B13","doi-asserted-by":"crossref","first-page":"e000916","DOI":"10.1136\/rmdopen-2019-000916","article-title":"Glucocorticoid withdrawal in systemic lupus erythematosus: are remission and low disease activity reliable starting points for stopping treatment? A real-life experience","volume":"5","author":"Tani","year":"2019","journal-title":"RMD Open"},{"key":"2021121823172969600_keab155-B14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.7326\/M14-2235","article-title":"Predictors of pregnancy outcomes in patients with lupus: a cohort study","volume":"163","author":"Buyon","year":"2015","journal-title":"Ann Intern Med"},{"key":"2021121823172969600_keab155-B15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13075-020-2139-9","article-title":"Low frequency of flares during pregnancy and post-partum in stable lupus patients","volume":"22","author":"Davis-Porada","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"2021121823172969600_keab155-B16","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/rheumatology\/39.9.1014","article-title":"Outcome of lupus pregnancy: a controlled study","volume":"39","author":"Georgiou","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"2021121823172969600_keab155-B17","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/01443615.2017.1381673","article-title":"Pregnancy complicated by systemic lupus erythematosus and its outcome over 10 years","volume":"38","author":"Khan","year":"2018","journal-title":"J Obstet Gynaecol"},{"key":"2021121823172969600_keab155-B18","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1177\/0961203316686704","article-title":"Systemic lupus erythematosus and risk of preterm birth: a systematic review and meta-analysis of observational studies","volume":"26","author":"Wei","year":"2017","journal-title":"Lupus"},{"key":"2021121823172969600_keab155-B19","doi-asserted-by":"crossref","first-page":"e104375","DOI":"10.1371\/journal.pone.0104375","article-title":"Pregnancy-related systemic lupus erythematosus: clinical features, outcome and risk factors of disease flares\u2013a case control study","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"key":"2021121823172969600_keab155-B20","first-page":"1","article-title":"Pregnancy outcomes in systemic lupus erythematosus (SLE) women","volume":"40","author":"Kalok","year":"2019","journal-title":"Horm Mol Biol Clin Investig"},{"key":"2021121823172969600_keab155-B21","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1177\/0961203310397967","article-title":"Predictors of maternal and fetal outcomes in pregnancies of patients with systemic lupus erythematosus","volume":"20","author":"Kwok","year":"2011","journal-title":"Lupus"},{"key":"2021121823172969600_keab155-B22","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/acr.23621","article-title":"Patient-reported disease activity and adverse pregnancy outcomes in systemic lupus erythematosus and rheumatoid arthritis","volume":"71","author":"Harris","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2021121823172969600_keab155-B23","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1136\/ard.2004.022442","article-title":"Clinical predictors of fetal and maternal outcome in Chinese patients with systemic lupus erythematosus","volume":"63","author":"Mok","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"2021121823172969600_keab155-B24","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/art.20864","article-title":"The impact of increased lupus activity on obstetric outcomes","volume":"52","author":"Clowse","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2021121823172969600_keab155-B25","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1191\/0961203303lu2006oa","article-title":"Prospective study of systemic lupus erythematosus pregnancies","volume":"13","author":"Petri","year":"2004","journal-title":"Lupus"},{"key":"2021121823172969600_keab155-B26","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.ajog.2005.02.063","article-title":"Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus","volume":"192","author":"Chakravarty","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"2021121823172969600_keab155-B27","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/annrheumdis-2017-211641","article-title":"Influence of disease activity and medications on offspring birth weight, pre-eclampsia and preterm birth in systemic lupus erythematosus: a population-based study","volume":"77","author":"Skorpen","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2021121823172969600_keab155-B28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jaut.2016.07.010","article-title":"Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century. A prospective multicenter study","volume":"74","author":"Moroni","year":"2016","journal-title":"J Autoimmun"},{"key":"2021121823172969600_keab155-B29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3109\/14767058.2011.572310","article-title":"Pregnancy in women with systemic lupus erythematosus: a retrospective study of 111 pregnancies in Chinese women","volume":"25","author":"Liu","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2021121823172969600_keab155-B30","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","article-title":"EULAR recommendations for women\u2019s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome","volume":"76","author":"Andreoli","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021121823172969600_keab155-B31","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/acr.24130","article-title":"2020 American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2021121823172969600_keab155-B32","first-page":"1","article-title":"Maternal and perinatal outcome in women with systemic lupus erythematosus: a retrospective bicenter cohort study","volume":"2017","author":"Kroese","year":"2017","journal-title":"J Immunol Res"},{"key":"2021121823172969600_keab155-B33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1586\/eci.12.36","article-title":"Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management","volume":"8","author":"Stojan","year":"2012","journal-title":"Expert Rev Clin Immunol"},{"key":"2021121823172969600_keab155-B34","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7150\/ijms.8.577","article-title":"Pregnancy outcomes and appropriate timing of pregnancy in 183 pregnancies in Korean patients with SLE","volume":"8","author":"Ko","year":"2011","journal-title":"Int J Med Sci"},{"key":"2021121823172969600_keab155-B35","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2215\/CJN.00240110","article-title":"A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis","volume":"5","author":"Smyth","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021121823172969600_keab155-B36","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2021121823172969600_keab155-B37","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/0002-9378(88)90090-7","article-title":"The classification and definition of the hypertensive disorders of pregnancy","volume":"158","author":"Davey","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"2021121823172969600_keab155-B38","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","article-title":"Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice","volume":"72","author":"Brown","year":"2018","journal-title":"Hypertension"},{"key":"2021121823172969600_keab155-B39","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/uog.15884","article-title":"Consensus definition of fetal growth restriction: a Delphi procedure","volume":"48","author":"Gordijn","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2021121823172969600_keab155-B40","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.berh.2017.09.011","article-title":"Pregnancy in systemic lupus erythematosus and antiphospholipid syndrome","volume":"31","author":"Fischer-Betz","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2021121823172969600_keab155-B41","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0140-6736(06)68397-9","article-title":"WHO analysis of causes of maternal death: a systematic review","volume":"367","author":"Khan","year":"2006","journal-title":"Lancet"},{"key":"2021121823172969600_keab155-B42","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1113\/JP271402","article-title":"The consequences of fetal growth restriction on brain structure and neurodevelopmental outcome","volume":"594","author":"Miller","year":"2016","journal-title":"J Physiol"},{"key":"2021121823172969600_keab155-B43","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/humupd\/dms020","article-title":"Anticardiolipin antibodies and recurrent early pregnancy loss: a century of equivocal evidence","volume":"18","author":"Clark","year":"2012","journal-title":"Human Reprod Update"},{"key":"2021121823172969600_keab155-B44","doi-asserted-by":"crossref","first-page":"hoy004","DOI":"10.1093\/hropen\/hoy004","article-title":"ESHRE guideline: recurrent pregnancy loss","volume":"2018","author":"Bender Atik","year":"2018","journal-title":"Hum Reprod Open"},{"key":"2021121823172969600_keab155-B45","first-page":"273","article-title":"The perils of the imperfect expectation of the perfect baby","volume":"214","author":"Chervenak","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"2021121823172969600_keab155-B46","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2141.2012.09112.x","article-title":"Pregnancy loss and thrombophilia: the elusive link","volume":"157","author":"Bennett","year":"2012","journal-title":"Br J Haematol"},{"key":"2021121823172969600_keab155-B47","first-page":"101","article-title":"The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies","volume":"203","author":"Sciascia","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"2021121823172969600_keab155-B48","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1177\/0961203319843343","article-title":"Hydroxychloroquine treatment during pregnancy in lupus patients is associated with lower risk of preeclampsia","volume":"28","author":"Seo","year":"2019","journal-title":"Lupus"},{"key":"2021121823172969600_keab155-B49","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1055\/s-0039-3402752","article-title":"Does hydroxychloroquine protect against preeclampsia and preterm delivery in systemic lupus erythematosus pregnancies?","volume":"37","author":"Do","year":"2020","journal-title":"Am J Perinatol"},{"key":"2021121823172969600_keab155-B50","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1191\/096120301678646137","article-title":"Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study","volume":"10","author":"Levy","year":"2001","journal-title":"Lupus"},{"key":"2021121823172969600_keab155-B51","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1002\/art.22159","article-title":"Hydroxychloroquine in lupus pregnancy","volume":"54","author":"Clowse","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2021121823172969600_keab155-B52","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/0961203314555352","article-title":"Hydroxychloroquine and pregnancy on lupus flares in Korean patients with systemic lupus erythematosus","volume":"24","author":"Koh","year":"2015","journal-title":"Lupus"},{"key":"2021121823172969600_keab155-B53","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s10067-012-1941-4","article-title":"Impact of previous lupus nephritis on maternal and fetal outcomes during pregnancy","volume":"31","author":"Saavedra","year":"2012","journal-title":"Clin Rheumatol"},{"key":"2021121823172969600_keab155-B54","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jaut.2016.06.012","article-title":"Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study","volume":"74","author":"Moroni","year":"2016","journal-title":"J Autoimmun"},{"key":"2021121823172969600_keab155-B55","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1191\/096120399680411272","article-title":"Assessing disease activity in SLE patients during pregnancy","volume":"8","author":"Buyon","year":"1999","journal-title":"Lupus"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab155\/36973291\/keab155.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/12\/5610\/41820254\/keab155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/12\/5610\/41820254\/keab155.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T18:24:11Z","timestamp":1639851851000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/12\/5610\/6137791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,16]]},"references-count":55,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,2,16]]},"published-print":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab155","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,1]]},"published":{"date-parts":[[2021,2,16]]}}}